Compounds > cytarabine

cytarabine and Refractory Anemia

cytarabine has been researched along with Refractory Anemia in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19905 (35.71)18.7374
1990's5 (35.71)18.2507
2000's3 (21.43)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Advani, AS; Charman, A; Cortes, J; Feldman, E; Kantarjian, H; Rizzieri, D; Spruyt, R; Toal, M; Yee, K1
Breitenbuecher, F; Fischer, T; Gamm, H; Gschaidmeier, H; Hess, G; Huber, C; Kindler, T; Kirkpatrick, CJ; Marx, A1
Chang, YW; Cho, HC; Cho, HI; Hur, M; Kim, SH; Kim, YR; Lee, KM; Park, YI1
Ahmad, I; André, M; Bennani, J; Bron, D; Dargent, JL; Meuleman, N; Ngirabacu, MC; Ravoet, C; Ysebrant, L1
Attal, M; Brousset, P; Dastugue, N; Demur, C; Duchayne, E; Rigal-Huguet, F; Robert, A; Rubie, H1
Arakawa, M; Chou, T; Hayashi, N; Ishizuka, Y; Ito, S; Ogawa, O; Saeki, T; Tsukada, H; Wakabayashi, M1
Bustillo, M; García-Torremocha, MS; Sastre, JL; Suárez-Gago, M; Ulibarrena, C; Vázquez, MO1
Arimori, S; Nagao, T; Yonekura, S1
Bauters, F; Fenaux, P; Jouet, JP; Lai, JL; Morel, P; Rose, C1
Miyazaki, T; Morioka, M; Sakurada, K1
Boutard, P; Guihard, J; Reman, O1
Gallo, JH; Rozenberg, MC1
Delacrétaz, F; Mermillod, B; Piguet, D; Schmidt, PM1
Akasaka, S; Ishikura, H; Izumi, Y; Mochizuki, T; Okazaki, T; Sawada, H; Tashima, M; Uchino, H; Usui, T; Yamagishi, M1

Trials

2 trial(s) available for cytarabine and Refractory Anemia

ArticleYear
Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study.
    The Lancet. Oncology, 2013, Volume: 14, Issue:4

    Topics: Aged; Aged, 80 and over; Anemia, Refractory; Cytarabine; Disease-Free Survival; Female; Glycine; Humans; Hydroxamic Acids; Leukemia, Monocytic, Acute; Male; Middle Aged; Recurrence; Remission Induction

2013
Intensified conditioning regimen with busulfan followed by allogeneic BMT in children with myelodysplastic syndromes.
    Bone marrow transplantation, 1994, Volume: 13, Issue:6

    Topics: Anemia, Refractory; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Cytarabine; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Methotrexate; Myelodysplastic Syndromes; Transplantation, Homologous; Whole-Body Irradiation

1994

Other Studies

12 other study(ies) available for cytarabine and Refractory Anemia

ArticleYear
Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AML.
    Blood, 2003, Apr-15, Volume: 101, Issue:8

    Topics: Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow; Cytarabine; Daunorubicin; Disease Progression; Drug Resistance, Neoplasm; Enzyme Inhibitors; Exons; Humans; Imatinib Mesylate; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Recurrence; Remission Induction; Salvage Therapy

2003
Protein 4.1 deficiency and deletion of chromosome 20q are associated with acquired elliptocytosis in myelodysplastic syndrome.
    Clinical and laboratory haematology, 2004, Volume: 26, Issue:1

    Topics: Aged; Anemia, Refractory; Antibiotics, Antineoplastic; Chromosome Deletion; Chromosomes, Human, Pair 20; Cytarabine; Cytoskeletal Proteins; Elliptocytosis, Hereditary; Erythrocytes; Humans; Idarubicin; Immunosuppressive Agents; Male; Membrane Proteins; Myelodysplastic Syndromes; Pancytopenia

2004
Long-term follow-up of autologous peripheral blood stem cell transplantation in the treatment of a patient with acute panmyelosis with myelofibrosis.
    Haematologica, 2006, Volume: 91, Issue:12 Suppl

    Topics: Acute Disease; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Erythropoietin; Etoposide; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Primary Myelofibrosis; Recombinant Proteins; Transplantation Conditioning; Transplantation, Autologous; Whole-Body Irradiation

2006
Disseminated Mycobacterium avium-intracellulare infection in a patient with myelodysplastic syndrome (refractory anemia).
    American journal of hematology, 1994, Volume: 45, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Anemia, Refractory; Bone Marrow; CD4 Antigens; Cytarabine; Dose-Response Relationship, Drug; Female; Gastric Juice; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophage Colony-Stimulating Factor; Mycobacterium avium-intracellulare Infection; Myelodysplastic Syndromes; Recombinant Proteins; T-Lymphocytes; Time Factors

1994
Long-term disappearance of previous chromosomal abnormalities in myelodysplastic syndromes treated with low dose cytosine arabinoside and granulocyte/macrophage-colony stimulating factor.
    Haematologica, 1998, Volume: 83, Issue:8

    Topics: Aged; Anemia, Refractory; Anemia, Sideroblastic; Chromosome Aberrations; Cytarabine; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors

1998
Essential thrombocythemia developing into refractory anemia and complicated by acute myeloid leukemia.
    Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:10

    Topics: Aged; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cytarabine; Daunorubicin; Humans; Karyotyping; Leukemia, Myeloid; Male; Mercaptopurine; Prednisolone; Thrombocythemia, Essential

1992
Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy.
    British journal of haematology, 1991, Volume: 77, Issue:4

    Topics: Adolescent; Adult; Aged; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Antibiotics, Antineoplastic; Cytarabine; Drug Therapy, Combination; Female; Humans; Karyotyping; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Prognosis; Remission Induction

1991
[Therapy of the preleukemic state: effect of androgens on refractory anemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:6

    Topics: Adult; Aged; Androgens; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Blast Crisis; Cholecalciferol; Chromosome Aberrations; Cytarabine; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Preleukemia; Prognosis

1988
Efficacy of low-dose Aracytine in 3 cases of refractory anemia in transformation in children.
    Nouvelle revue francaise d'hematologie, 1988, Volume: 30, Issue:4

    Topics: Anemia, Refractory; Child, Preschool; Cytarabine; Down Syndrome; Female; Humans; Male; Remission Induction

1988
Response of refractory anemia to low-dose cytosine arabinoside.
    Australian and New Zealand journal of medicine, 1986, Volume: 16, Issue:2

    Topics: Aged; Anemia, Refractory; Blood Cell Count; Blood Transfusion; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Male

1986
[Retrospective study of 30 cases of myelodysplastic syndrome according to the French-American-British classification].
    Schweizerische medizinische Wochenschrift, 1987, Jan-10, Volume: 117, Issue:2

    Topics: Aged; Anemia, Refractory; Anemia, Sideroblastic; Bone Marrow; Cytarabine; Female; Hematopoietic Stem Cells; Humans; International Cooperation; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Retrospective Studies

1987
Clinical effect of low dose ara-C in twenty patients with acute nonlymphocytic leukemia, atypical leukemia, and refractory anemia with excess of blasts.
    Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society, 1986, Volume: 49, Issue:1

    Topics: Acute Disease; Adult; Aged; Anemia, Refractory; Cytarabine; Female; Humans; Leukemia; Male; Middle Aged

1986